GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navana Pharmaceuticals PLC (DHA:NAVANAPHAR) » Definitions » Cash, Cash Equivalents, Marketable Securities

Navana Pharmaceuticals (DHA:NAVANAPHAR) Cash, Cash Equivalents, Marketable Securities : BDT0.00 Mil (As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Navana Pharmaceuticals Cash, Cash Equivalents, Marketable Securities?


Navana Pharmaceuticals Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Navana Pharmaceuticals's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navana Pharmaceuticals Cash, Cash Equivalents, Marketable Securities Chart

Navana Pharmaceuticals Annual Data
Trend
Cash, Cash Equivalents, Marketable Securities

Navana Pharmaceuticals Semi-Annual Data
Cash, Cash Equivalents, Marketable Securities

Navana Pharmaceuticals Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Navana Pharmaceuticals  (DHA:NAVANAPHAR) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Navana Pharmaceuticals Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Navana Pharmaceuticals's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Navana Pharmaceuticals Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
Road 4, House 99, Block B, Banani, Dhaka, BGD, 1213
Navana Pharmaceuticals PLC operates its business under two divisions namely Veterinary Division and Human Health Division. Veterinary Division manufactures and markets high-quality veterinary medicine and feed supplements for different segments including poultry, dairy and aqua products. Human Health Division operates its manufacturing facilities in strict compliance with WHO cGMP guidelines for the production of tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, eye drops, creams and ointments.

Navana Pharmaceuticals Headlines

No Headlines